Xtx Topco LTD Chemomab Therapeutics Ltd. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Xtx Topco LTD holds 24,929 shares of CMMB stock, worth $42,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,929
Previous 15,223
63.76%
Holding current value
$42,628
Previous $23,000
117.39%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CMMB
# of Institutions
17Shares Held
4.16MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$2.98 Million0.1% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.21MShares$2.08 Million0.51% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3744KShares$1.27 Million0.23% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$364,3180.07% of portfolio
-
Morgan Stanley New York, NY104KShares$178,5240.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $19.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...